Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients.

Standard

Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. / Hauschild, A; Michaelsen, J; Brenner, Winfried; Rudolph, P; Gläser, R; Henze, E; Christophers, E.

in: MELANOMA RES, Jahrgang 9, Nr. 2, 2, 1999, S. 155-161.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Hauschild, A, Michaelsen, J, Brenner, W, Rudolph, P, Gläser, R, Henze, E & Christophers, E 1999, 'Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients.', MELANOMA RES, Jg. 9, Nr. 2, 2, S. 155-161. <http://www.ncbi.nlm.nih.gov/pubmed/10380938?dopt=Citation>

APA

Vancouver

Hauschild A, Michaelsen J, Brenner W, Rudolph P, Gläser R, Henze E et al. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. MELANOMA RES. 1999;9(2):155-161. 2.

Bibtex

@article{ad27df2609bc4dda92a06a302e0d40ee,
title = "Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients.",
abstract = "Recent reports on the use of a quantitative measurement of S100B protein for the detection of metastatic melanoma have yielded promising results. In this study we evaluated 489 serum samples from 64 patients suffering from advanced melanoma (UICC/AJCC stage IV) to compare the sensitivity of a S100B immunoradiometric assay (IRMA) with that of conventional blood parameters as well as other known clinical prognostic factors. In a univariate statistical analysis, gender, bone metastasis, and lactate dehydrogenase and S100B levels in serum samples were found to be significant prognostic markers (P",
author = "A Hauschild and J Michaelsen and Winfried Brenner and P Rudolph and R Gl{\"a}ser and E Henze and E Christophers",
year = "1999",
language = "Deutsch",
volume = "9",
pages = "155--161",
journal = "MELANOMA RES",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients.

AU - Hauschild, A

AU - Michaelsen, J

AU - Brenner, Winfried

AU - Rudolph, P

AU - Gläser, R

AU - Henze, E

AU - Christophers, E

PY - 1999

Y1 - 1999

N2 - Recent reports on the use of a quantitative measurement of S100B protein for the detection of metastatic melanoma have yielded promising results. In this study we evaluated 489 serum samples from 64 patients suffering from advanced melanoma (UICC/AJCC stage IV) to compare the sensitivity of a S100B immunoradiometric assay (IRMA) with that of conventional blood parameters as well as other known clinical prognostic factors. In a univariate statistical analysis, gender, bone metastasis, and lactate dehydrogenase and S100B levels in serum samples were found to be significant prognostic markers (P

AB - Recent reports on the use of a quantitative measurement of S100B protein for the detection of metastatic melanoma have yielded promising results. In this study we evaluated 489 serum samples from 64 patients suffering from advanced melanoma (UICC/AJCC stage IV) to compare the sensitivity of a S100B immunoradiometric assay (IRMA) with that of conventional blood parameters as well as other known clinical prognostic factors. In a univariate statistical analysis, gender, bone metastasis, and lactate dehydrogenase and S100B levels in serum samples were found to be significant prognostic markers (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 9

SP - 155

EP - 161

JO - MELANOMA RES

JF - MELANOMA RES

SN - 0960-8931

IS - 2

M1 - 2

ER -